Yield10 Bioscience, Inc. Overview
Pro stress-test →Yield10 is in the business of "building better plants" to achieve step-change increases in the yield of major food and feed crops. The company focuses on Camelina oilseeds for production of omega-3 fatty acids and as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel, and sustainable aviation fuel. The company is in critical financial distress following a Chapter 11 bankruptcy filing in December 2024.
Strategic Profile
Pro stress-test →Yield10 brings unique capabilities in advanced metabolic engineering and systems biology to optimize photosynthesis and carbon efficiency in crops to increase grain or biomass yield. The commercial plan is based on establishing a grain contracting business leveraging proprietary elite Camelina seed varieties, focusing on low-carbon intensity feedstock oil for biofuels and omega-3 oils for nutritional applications. On December 6, 2024, Yield10 Bioscience filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Competitive Landscape
Pro stress-test →Yield10 competes in agricultural biotechnology and crop trait development against larger players like Bayer-Monsanto (genetically modified seeds and traits), Corteva Agriscience (crop genetics), and BASF (agricultural chemicals and biotech). Smaller competitors in specialty crops and omega-3 extraction include Oemine and Renaissance BioScience. The company's Camelina platform and gene-editing approach differentiate it, but scale and capital constraints limit competitive reach.
Industry Context
Yield10 Bioscience, Inc. operates in Agricultural biotechnology and crop traits.
Key facts
Founded: 1992 · Headquarters: Woburn, MA, US · Employees: ~29 (as of February 2026) · Revenue: $0.45M (Q2 2024) · Market cap: N/A